India’s Marksans Pharma is seeking approval from its shareholders to divest or lease out its two active pharmaceutical ingredient (API) …

Includes online petition against NICE decision, Shire brings ADHD to Twitter, ViiV joins Twitter, Doctors.net.uk launches iPhone app and Diabetes …
NICE has rejected Sanofi-Aventis’ new anti-blood clot treatment Multaq (dronedarone) for use on the NHS because of its cost. According …

AstraZeneca’s Bruno Angelici has been appointed Chevalier dans l`Ordre National de la Légion d`honneur in the French New Year honours …
The Conservative Party’s draft manifesto on the NHS has been given a cautious welcome by the King’s Fund, which says …

The UK Department of Health has started a consultation on proposals that would allow generic medicines to be substituted for …
Kendle has appointed Stephen Cutler to the position of senior vice president and chief operating officer.Dr Cutler has a track …

Japanese drugmaker Eisai has started operations at a manufacturing and research facility in Visakhapatnam, southern India, which will be the …
The Department of Health has appointed its first national clinical director for informatics. Charles Gutteridge has been medical director at …
AstraZeneca is to buy infection research firm Novexel for $350 million. The manufacturer will take all the French company’s shares …
Ranbaxy has shaken up its operations in China with the divestment of its stake a joint venture with Guangzhou Baiyunshan …
Woodley Equipment has appointed David Wood medical electronics manager and Joanne Platt as customer service representative. David will be instrumental …
Our round-up of developments in manufacturing includes contracts for DSM and Venturepharm, facility updates from Indoco and Jubilant, and an …

The government has launched its latest weapon in the battle to wrest people away from their nicotine addiction. The NHS …

Pharma manufacturers have welcomed the passing of the US Senate’s healthcare reform bill on Christmas Eve. Ken Johnson, senior vice …
DMV-Fonterra Excipients has agreed to buy the product range of FrieslandCampina Domo for 52.5 million euros in a deal that …
An independent committee of directors of Alcon has expressed its disappointment with the recent takeover bid from Novartis, saying the …
Genzyme has taken the decision to move the fill and finish stages of its manufacturing process to Hospira in order …

Andrew Dillon, chief executive of the National Institute for Health and Clinical Excellence (NICE), has been knighted in the 2010 …

Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …